Effect of exercise training on plasma visfatin and eotaxin levels

被引:81
作者
Choi, K. M.
Kim, J. H.
Cho, G. J.
Baik, S. H.
Park, H. S.
Kim, S. M. [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 152050, South Korea
[2] Korea Univ, Guru Hosp, Coll Med, Dept Family Med, Seoul 152050, South Korea
[3] Guro Gu Publ Hlth Ctr, Seoul 152055, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Family Med, Seoul 138736, South Korea
关键词
D O I
10.1530/EJE-07-0127
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: Visfatin, a novel adipokine, was revealed to be associated with obesity and to have insulin-mimetic effect. Eotaxin, which is an important chemokine in asthma, was recently reported to be associated with obesity in mice and humans. We evaluated the effect of exercise training on plasma visfatin and cotaxin levels in association with cardiovascular risk factors. Design: Forty-eight non-diabetic Korean women were evaluated before and after a 1.2 week exercise program including aerobic exercise (45 min/session, 300 Kcal/day) and muscle strength training (20 min/session, 100 Kcal/day) five times per week. Results: Plasma visfatin concentrations were elevated in obese subjects (body mass index, BMI >= 25 kg/m(2)) when compared with non-obese subjects (16.4 +/- 13.4 ng/ml vs 7.7 +/- 5.2 ng/ml, P = 0.006), and cotaxin concentrations were elevated in subjects with central obesity (waist circumference, WC 80 cm) when compared with those without central obesity (73.6 +/- 1.7.8pg/ml vs 64.2 +/- 4.2 pg/ml, P = 0.005). In multiple regression analyses, visfatin levels were associated with BMI (R-2 = 0.255) and eotaxin levels were associated with WC and body weight (R-2 = 0.307). After the exercise program, body weight, blood pressure, fasting glucose, and insulin resistance of participants were decreased. Furthermore, plasma visfatin levels were significantly decreased from 13.6 +/- 12.0 to 7.7 +/- 7.9 ng/ml (P = 0.026) and eotaxin levels were reduced from 72.0 +/- 16.7 to 66.9 +/- 14.2 pg/ml (P = 0.018). Conclusions: Exercise training with weight loss induced a significant reduction of plasma visfatin and eotaxin levels in non-diabetic Korean women.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 32 条
[1]
Editorial: Visfatin - A true or false trail to type 2 diabetes mellitus [J].
Arner, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :28-30
[2]
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [J].
Berndt, J ;
Klöting, N ;
Kralisch, S ;
Kovacs, P ;
Fasshauer, M ;
Schön, MR ;
Stumvoll, M ;
Blüher, M .
DIABETES, 2005, 54 (10) :2911-2916
[3]
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus [J].
Chen, MP ;
Chung, FM ;
Chang, DM ;
Tsai, JCR ;
Huang, HF ;
Shin, SJ ;
Lee, YJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :295-299
[4]
Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome [J].
Duncan G.E. .
Current Diabetes Reports, 2006, 6 (1) :29-35
[5]
Eriksson J, 1997, DIABETOLOGIA, V40, P125
[6]
Association between obesity and asthma in 4-11 year old children in the UK [J].
Figueroa-Muñoz, JI ;
Chinn, S ;
Rona, RJ .
THORAX, 2001, 56 (02) :133-137
[7]
Overweight and obesity in the United States: prevalence and trends, 1960-1994 [J].
Flegal, KM ;
Carroll, MD ;
Kuczmarski, RJ ;
Johnson, CL .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (01) :39-47
[8]
RETRACTED: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007) [J].
Fukuhara, A ;
Matsuda, M ;
Nishizawa, M ;
Segawa, K ;
Tanaka, M ;
Kishimoto, K ;
Matsuki, Y ;
Murakami, M ;
Ichisaka, T ;
Murakami, H ;
Watanabe, E ;
Takagi, T ;
Akiyoshi, M ;
Ohtsubo, T ;
Kihara, S ;
Yamashita, S ;
Makishima, M ;
Funahashi, T ;
Yamanaka, S ;
Hiramatsu, R ;
Matsuzawa, Y ;
Shimomura, I .
SCIENCE, 2005, 307 (5708) :426-430
[9]
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding [J].
Haider, DG ;
Schindler, K ;
Schaller, G ;
Prager, G ;
Wolzt, M ;
Ludvik, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1578-1581
[10]
*HLTH COMM AUSTR P, 2000, AS PAC PERSP RED OB